Announced Wed, 15 Apr · 17:08 IST
Subsidiary Optival gets 2 drug license suspension orders
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹867.00
prior close
₹870.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4-0.2-0.0-0.4+1.4-0.0+0.9+2.8+5.5+3.9+0.8+7.0+0.3-6.2
Up moveDown movePending
AI summary
Medplus Health Services' subsidiary Optival Health Solutions received two drug license suspension orders: a 7-day suspension for its Ameenapeta Eluru (AP) store and a 2-day suspension for its Saheednagar, Bhubaneswar (Odisha) store. Both were issued under Rule 65 of the Drugs and Cosmetics Act, 1940. Combined potential revenue loss is approximately Rs 6.81 lakhs (Rs 5.85 lakhs + Rs 0.96 lakhs). No broader financial impact on the listed entity was disclosed.
Likely market impact
Minor impact — combined potential revenue loss of ~Rs 6.81 lakhs from two store suspensions; financially immaterial for the company.